Chase AIPricingFAQs
Display currency
Loading news…

Syapse

ClosedOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 MediumHeat score — how much recent activity & attention the company has (web traffic, news, hiring).
San Francisco, California, United States Founded 2008 51-100 employees For Profit

Syapse is a real-world evidence company dedicated to extinguishing the fear and burden of serious disease by advancing real-world care

Syapse was acquired by N-Power Medicine in 2025.
Total Funding
Available in Pro
Last Funding
Available in Pro
Acquisitions
0
Monthly Visits
Available in Pro
Contacts
137

Company Details

Funding & Financials

Pro
Total funding
Funding rounds
Last funding
Last funding type
Last funding date
Funding status
Total equity funding
Revenue range

IPO & Stock

IPO status
Private
Valuation range
$100M to $500M

Web Traffic

Pro
Monthly visits
Global traffic rank
6-mo avg visits
Visit duration (s)
Pages / visit
Bounce rate
Rank change (mo)

Technology & IP

Active technologies
53
Active products
28
IT spend
$9M

Company Info

Founded
2008
Employees
51-100
Operating status
Closed
Company type
For Profit
Org types
company
Founders
2
News articles
63
HQ
San Francisco, California, United States
Region
San Francisco Bay Area, West Coast, Western US
Exit date
Jan 12, 2025

Signals & Scores

Heat score
Medium
Trend (7d)
-0.1
Trend (30d)
0
Trend (90d)
-0.8

Key People at Syapse

Chief Commercial Officer
Chief Data and Product Development Officer
Senior Vice President, Biomarker Data and Laboratory Medicine
137
professional contacts at Syapse
Contact execs at Syapse

Explore 200,000+ acquisitions — free

Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.

Explore all acquisitions

Recent News related to Syapse

Loading news…

FAQs about Syapse

People who checked this page also checked these

Browse the full Acquirezy directory.
Syapse - Company Profile, Full Acquisitions List, Funding and Investments